This study is to evaluate the effectiveness of oriental medicine-based infertility treatment and to examine the validity of the oriental medicine-based infertility treatment program through a systematic review. The literature search database included not only PubMed, DBpia, and RISS (Research Information Sharing Service) but also OASIS (Oriental Medicine Advanced Searching Integrated System) and Korean Traditional Knowledge Portal. Among 575 articles that searched, only three papers were randomized controlled trials and could be included for the evaluation of the effects of oriental medicine-based infertility treatment. There was no study showing the effectiveness of oriental medicine-based infertility treatment alone. Among 5,165 articles that searched, only 15 studies could be included for the evaluation of the natural pregnancy rate of infertile patients. These studies reported the natural pregnancy rates from 20.3% to 41.9%. As pregnancy rates ranged from 23.8% to 27.6% after the oriental medicine-based infertility treatment supporting programs, we cannot conclude that pregnancy rates for infertile patients might increase by this project. Therefore, there is a need to reconsider whether the oriental medicine-based infertility treatment program should continue in the future.
Acupuncture ; Humans ; Infertility ; Information Dissemination ; Medicine, East Asian Traditional ; Pregnancy Rate ; Pregnancy

This study is to evaluate the effectiveness of oriental medicine-based infertility treatment and to examine the validity of the oriental medicine-based infertility treatment program through a systematic review. The literature search database included not only PubMed, DBpia, and RISS (Research Information Sharing Service) but also OASIS (Oriental Medicine Advanced Searching Integrated System) and Korean Traditional Knowledge Portal. Among 575 articles that searched, only three papers were randomized controlled trials and could be included for the evaluation of the effects of oriental medicine-based infertility treatment. There was no study showing the effectiveness of oriental medicine-based infertility treatment alone. Among 5,165 articles that searched, only 15 studies could be included for the evaluation of the natural pregnancy rate of infertile patients. These studies reported the natural pregnancy rates from 20.3% to 41.9%. As pregnancy rates ranged from 23.8% to 27.6% after the oriental medicine-based infertility treatment supporting programs, we cannot conclude that pregnancy rates for infertile patients might increase by this project. Therefore, there is a need to reconsider whether the oriental medicine-based infertility treatment program should continue in the future.

PURPOSE: Assessing the immunogenicity of a single dose of hepatitis A virus (HAV) vaccines is important because some people receive only a single dose. However, previous studies have shown variable results and have not examined the effects of demographic characteristics other than gender. This study was performed to examine the immunogenicity of a single dose of HAV vaccine according to the vaccine type and demographic characteristics in young adults. MATERIALS AND METHODS: Seronegative medical school students were randomly allocated to receive either Havrix or Epaxal. RESULTS: After approximately 11 months, the seroconversion rate in 451 participants was 80.7%. In men, the Havrix group showed a significantly higher seroconversion rate (81.9%) than the Epaxal group (69.2%), whereas both vaccine groups showed similarly high immunogenicity in women (Havrix: 90.1%, Epaxal: 92.9%; P for interaction=0.062). According to the results of a multivariate analysis, Epaxal showed significantly lower immunogenicity than Havrix only in men. Age, obesity, drinking, smoking, and follow-up time did not significantly affect seroconversion in either gender. CONCLUSION: The seroconversion rate of single-dose HAV vaccines was low in men, particularly in those who received Epaxal. Our results suggest that gender effects should be considered when comparing the immunogenicity of different HAV vaccines.
Adolescent ; Adult ; Female ; Hepatitis A/*immunology/*prevention & control ; Hepatitis A Vaccines ; Hepatitis A Virus, Human/*immunology/*pathogenicity ; Humans ; Male ; Young Adult